Track Your Future Recoveries Withsnaptrade iconConnect Account

Stemline Therapeutics, Inc. Securities Litigation Settlement
(NASDAQ: STML)
Settlement

Claim Deadline: October 23, 2019

Settlement Fund: $680,000

Settlement Class

All persons or entities that purchased or otherwise acquired Stemline Therapeutics, Inc. (“Stemline” or the “Company”)  common stock during the period from January 20, 2017 to February 1, 2017, both dates inclusive

Important Documents

Settlement Notice

Proof Of Claim

Settlement Status

Disbursed

Class Period

January 19, 2017 - May 02, 2017

Settlement Hearing Date

September 23, 2019

Opt-Out Deadline

September 02, 2019

Settlement Website

https://www.strategicclaims.net/stemline-therapeutics/

Claims Admin

Strategic Claims Services
Stemline Therapeutics, Inc. Securities Litigation 
c/o Strategic Claims Services 
P.O. Box 230 
600 N. Jackson St., Ste. 205 
Media, PA 19063
+1 440-04_-____
info@strategicclaims.net

Levi & Korsinsky did not act as lead counsel or otherwise participate in litigating the above class action and provides this information to remind class members of the deadline to submit a claim for a share of any of the settlement fund.